-
EP0523013
European procedure
Extract from the Register of European Patents
EP About this file: EP0523013
| EP0523013 - Use of benzimidazoline-2-oxo-1-carboxylic acid derivatives in the treatment of organic mental diseases [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 26.10.1995 Database last updated on 03.09.2024 | Most recent event Tooltip | 14.03.2003 | Change - lapse in a contracting state Updated state(s): MC | published on 02.05.2003 [2003/18] | Applicant(s) | For all designated states BOEHRINGER INGELHEIM ITALIA S.p.A. Via Pellicceria, 10 50123 Firenze / IT | [N/P] |
| Former [1993/02] | For all designated states BOEHRINGER INGELHEIM ITALIA S.p.A. Via Pellicceria, 10 I-50123 Firenze / IT | Inventor(s) | 01 /
Brambilla, Alessandro Via Brioschi, 27 Milano / IT | 02 /
Turconi, Marco Via Gramsci, 20 Voghera (Pavia) / IT | 03 /
Schiantarelli, Pierino Via S. Franca, 49/B Piacenza / IT | 04 /
Borsini, Franco Via G. Bruno, 70 Prato (Firenze) / IT | 05 /
Ladinsky, Herbert Via dei Gracchi, 30 Milano / IT | [1993/02] | Representative(s) | Aimi, Luciano, et al c/o Società Italiana Brevetti S.p.A. Via Carducci 8 20123 Milano / IT | [N/P] |
| Former [1993/02] | Aimi, Luciano, et al c/o Società Italiana Brevetti S.p.A. Via Carducci 8 I-20123 Milano / IT | Application number, filing date | 92830346.0 | 02.07.1992 | [1993/02] | Priority number, date | IT1991MI01845 | 04.07.1991 Original published format: IT MI911845 | [1993/02] | Filing language | IT | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | EP0523013 | Date: | 13.01.1993 | Language: | EN | [1993/02] | Type: | A3 Search report | No.: | EP0523013 | Date: | 27.01.1993 | Language: | EN | [1993/04] | Type: | B1 Patent specification | No.: | EP0523013 | Date: | 21.12.1994 | Language: | EN | [1994/51] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 09.12.1992 | Classification | IPC: | A61K31/435 | [1993/02] | CPC: |
A61K31/435 (EP);
A61K31/415 (KR);
A61P25/18 (EP);
A61P25/28 (EP)
| Designated contracting states | AT, BE, CH, DE, DK, ES, FR, GB, GR, IT, LI, LU, MC, NL, PT, SE [1993/02] | Title | German: | Verwendung von Benzimidazolin-2-oxo-1-Carbonsäurederivaten bei der Behandlung organischer Gehirnerkrankungen | [1993/02] | English: | Use of benzimidazoline-2-oxo-1-carboxylic acid derivatives in the treatment of organic mental diseases | [1993/02] | French: | Utilisation des dérivés de l'acide benzimidazoline-2-oxo-1-carboxylique dans le traitement des maladies mentales organiques | [1993/02] | Examination procedure | 14.07.1993 | Examination requested [1993/37] | 20.08.1993 | Despatch of a communication from the examining division (Time limit: M04) | 10.12.1993 | Reply to a communication from the examining division | 08.02.1994 | Despatch of communication of intention to grant (Approval: Yes) | 16.06.1994 | Communication of intention to grant the patent | 27.08.1994 | Fee for grant paid | 27.08.1994 | Fee for publishing/printing paid | Opposition(s) | 22.09.1995 | No opposition filed within time limit [1995/50] | Fees paid | Renewal fee | 08.07.1994 | Renewal fee patent year 03 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | ES | 21.12.1994 | MC | 21.12.1994 | [2003/18] |
| Former [2003/17] | ES | 21.12.1994 | |
| MC | 02.07.1995 | ||
| Former [2002/25] | ES | 21.12.1994 | |
| MC | 21.12.1994 | ||
| Former [2001/24] | MC | 21.12.1994 | Documents cited: | Search | [Y]EP0190920 (ROBINS CO INC A H [US]); | [Y]EP0279990 (GLAXO GROUP LTD [GB]); | [XD]EP0309423 (ANGELI INST SPA [IT]) | [Y] - JOURNAL OF MEDICINAL CHEMISTRY, vol. 33, no. 8, 1990, pages 2101-2108, American Chemical Society; M. TURCONI et al.: "Synthesis of a new class of 2,3-dihydro-2-oxo-1H-benzimidazole-1-carboxylic acid derivatives as highly potent 5-HT3 receptor antagonists" | [Y] - NAUNYN-SCHMIEDEBERG'S ARCHIVES OF PHARMACOLOLOGY, vol. 343, no. 3, March 1991, pages 245-251, Springer-Verlag; A. DUMUIS et al.: "Azabicycloalkyl benzimidazolone derivatives as a novel class of potent agonists at the 5-HT4 receptor positively coupled to adenylate cyclase in brain" | [Y] - MEDICINAL RESEARCH REVIEWS, vol. 10, no. 4, October-December 1990, pages 441-475, John Wiley & Sons, Inc.; G.J. KILPATRICK et al.: "5-HT3 receptors" |